4//SEC Filing
NABI BIOPHARMACEUTICALS 4
Accession 0001396093-08-000001
$VXRTCIK 0000072444operating
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 3:48 PM ET
Size
6.7 KB
Accession
0001396093-08-000001
Insider Transaction Report
Form 4
FAHIM RAAFAT E F
DirectorPresident, CEO and CFO
Transactions
- Award
Common Stock
2008-01-22+50,000→ 176,730.422 total - Award
Common Stock
2008-01-22+7,000→ 183,730.422 total
Footnotes (1)
- [F1]Restricted Stock that vests in full on January 22, 2009.
Documents
Issuer
NABI BIOPHARMACEUTICALS
CIK 0000072444
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000072444
Filing Metadata
- Form type
- 4
- Filed
- Jan 23, 7:00 PM ET
- Accepted
- Jan 24, 3:48 PM ET
- Size
- 6.7 KB